I don't think this is over yet.
I think that there was an element of tiredness with all the recalls.
They have painted themselves into a corner. They have articulated a position and set a price that is well below $72, so it is going to be tough.
At the end of the day, Boston is going to run out of cash ahead of J&J. Boston's really going to have to go for broke.
J&J is flexing its muscles. That's why J&J has come back so aggressively.
Really, Abbott is bearing the brunt of this.
The lion's share of what will be divested is going to Abbott.
I just don't think this is over yet. Boston really feels this is a redefining move for them.
I would not be surprised to see J&J come back. They've got $16 billion in cash at the end of 2005. They have tremendous financial resources. It's up to them.
Copyright © 2024 Electric Goat Media. All Rights Reserved.